Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2015

Oct 6, 2015

31949_dirs_2015-10-06_a108dfcb-3a17-4536-b301-98217d805e24.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-05

Reporting Person: DOYLE WILLIAM F (Director, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-05 Ordinary Shares X 399659 $3.54 Acquired 1380874 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-05 Warrants $3.54 X 399659 Disposed 2015-10-11 Ordinary Shares (399659) Indirect

Footnotes

F1: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II. Mr. Doyle possesses sole voting and investment power over shares owned by WFD Ventures Fund II (subject to certain rights of the advisory board of WFD Ventures Fund II to approve sales of any of the shares owned by WFD Ventures Fund II).

F2: Currently exercisable as of the date hereof.